An Issue of Quality
December 17, 2015
2015 has been a difficult year for Indian pharma companies – and ASSOCHAM is calling for the country to get its “house in order”.
1 min read
Bridging the 'Omics Gap
December 17, 2015
A new personalized test aims to predict side effects
1 min read
AMA Ad-Block
December 17, 2015
The AMA calls for a ban on direct-to-consumer drug advertising in the US. But is such prohibition realistic?
1 min read
Let Construction Commence for Cell Manufacture
December 17, 2015
The UK aims high with a new manufacturing center designed to meet the needs of cell and gene therapies
1 min read
A Turbulent Transaction?
December 17, 2015
Pfizer and Allergan are to combine to form the world’s biggest pharma behemoth – but much attention has focused on the tax implications
1 min read
New Age Traveler
December 17, 2015
From Iceland’s volcanic springs to a lab in South Denmark; does the microbe Sulfolobus. islandicus hold the key to a drug’s safe transit through the gut?
1 min read
Smart Sensor Capsule
December 17, 2015
A capsule being developed in Ireland aims to contain not medicine, but process analytical technology
1 min read
Understanding Acceptable – Analytical Method – Submissions
December 17, 2015
Digesting regulatory guidance is not always easy, but understanding the main points – and then paying attention to the details – will improve your chances of success. Here, I break down the latest analytical guidance into seven bite size chunks to lend a h
1 min read
#Ebola
December 17, 2015
The Ebola epidemic spurred a tremendous amount of R&D in search of vaccines and treatments – and yet it was a relatively low impact global emergency compared with malaria. How can we incentivize development in other important health areas?
1 min read
A Dangerous Trend?
December 17, 2015
The reverse merger between Pfizer and Allergan is the most recent chapter in a decades-long transformation of the pharma industry, but I believe it also represents a rapid acceleration of a troubling trend.
1 min read
Data: Wanted Dead or Alive
December 17, 2015
Can R&D organizations really afford to kill off analytical data that could be used for future decision-making? Perhaps it’s time to breathe life back into analytical data environments.
1 min read
Sublingual Vaccines – A Taste of the Future?
December 17, 2015
It is well known that small molecules can be formulated in rapidly dispersing, dissolve-in-the-mouth tablets. But what if biologics and vaccines could also be delivered via the buccal or sublingual route?
1 min read
Making Media Better Than Average
December 16, 2015
Cell culture media developers used to focus on maximizing protein yield. But yields are yesterday’s problem...
1 min read
The Medicine Maker Innovation Awards
December 16, 2015
Welcome to The Medicine Maker inaugural Innovation Awards; recognizing the most exciting new technologies of 2015!
1 min read
Precision Medicine; Imprecise Manufacturing and Supply
December 16, 2015
Precision medicine holds much promise, but there’s no question that it will disrupt current manufacturing and downstream supply chain habits. Are companies up to the challenge? Or would they rather seek a quiet life?
1 min read
How to Get PR Right
December 16, 2015
How do your customers, your competitors, the press or even the public perceive your organization? Here, I offer my tips, tricks and thoughts on PR – and suggest why you might want to consider a smarter approach.
1 min read
Emerging Market Explorer
December 16, 2015
Sitting Down With... Raman Singh, President, Mundipharma Asia Pacific, Latin America, Middle East and Africa.
1 min read
New and Improved
December 16, 2015
New technologies in our Innovation Awards… and an expanded editorial team!
1 min read
Measuring Low-Level Polymorphic Contamination using Morphologically Directed Raman Spectroscopy
December 11, 2015
Polymorphic conversions are an ongoing problem in the pharmaceutical industry. Here we describe the use of Morphologically-Directed Raman Spectroscopy to distinguish and quantify particles of different polymorphic types of acetaminophen (paracetamol) within a mixture. MDRS is a flexible tool for root cause analysis, product quality and formulation development and is well-suited to identifying even low-level polymorphic contamination.
1 min read
Binding thermodynamics of substituted diaminopyrimidine renin inhibitors
November 24, 2015
See how thermodynamics can be used to improve your lead optimization process.
1 min read
